Human Health Aspects in Waste Biorefinery Technologies and Products

Climate change serves as a powerful catalyst, urging us to reevaluate our relationship with the planet. Its negative impacts are most notably seen in rising CO2 levels, which drive global temperature increases, as well as the growing waste production. Acknowledging these challenges has sparked the development of biorefinery technologies aimed at producing cleaner energy and sustainable products. Beyond reducing environmental harm, these innovations can indirectly benefit human health and well being. However, when introducing any product for human use, we must also consider its direct impact on the human body. Although biorefinery technologies generate bio-based products, this doesn't automatically guarantee they are entirely safe for human health. Engineered living materials (ELMs) offer a promising avenue within biorefinery technologies, as they combine biological functions with structural capabilities, potentially enhancing sustainability and reducing waste. However, given their dynamic nature, it is essential to thoroughly evaluate the interaction between these materials and human health to ensure they are safe for direct or indirect human exposure. Therefore, it is crucial to assess their potential influence on health to optimize production processes and ensure truly sustainable products that pose no harm to human health. One simple and effective method to evaluate the safety of these products is cytotoxicity testing. This involves testing the substance or product on human cells in vitro and observe their response to it. After exposure, the viability and morphology of the cells are examined to detect any potential toxic effects. As the famous Latin phrase reminds us, “sola dosis facit venenum” (the dose makes the poison) - even essential molecules like vitamins can be harmful if consumed in excessive amounts. This highlights the importance of determining the safe dosage for any substance we are exposed to. In the context of biorefinery technologies, understanding the balance between environmental friendliness and human safety is key to developing products that are both sustainable and non-toxic.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-10-11
DOI
https://doi.org/10.5281/zenodo.13990058
Primary Topic
MicroRNA in disease regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Human Health Aspects in Waste Biorefinery Technologies and Products

Zenodo (CERN European Organization for Nuclear Research)
MicroRNA in disease regulation
article

Human Health Aspects in Waste Biorefinery Technologies and Products

article en

Abstract

Climate change serves as a powerful catalyst, urging us to reevaluate our relationship with the planet. Its negative impacts are most notably seen in rising CO2 levels, which drive global temperature increases, as well as the growing waste production. Acknowledging these challenges has sparked the development of biorefinery technologies aimed at producing cleaner energy and sustainable products. Beyond reducing environmental harm, these innovations can indirectly benefit human health and well being. However, when introducing any product for human use, we must also consider its direct impact on the human body. Although biorefinery technologies generate bio-based products, this doesn't automatically guarantee they are entirely safe for human health. Engineered living materials (ELMs) offer a promising avenue within biorefinery technologies, as they combine biological functions with structural capabilities, potentially enhancing sustainability and reducing waste. However, given their dynamic nature, it is essential to thoroughly evaluate the interaction between these materials and human health to ensure they are safe for direct or indirect human exposure. Therefore, it is crucial to assess their potential influence on health to optimize production processes and ensure truly sustainable products that pose no harm to human health. One simple and effective method to evaluate the safety of these products is cytotoxicity testing. This involves testing the substance or product on human cells in vitro and observe their response to it. After exposure, the viability and morphology of the cells are examined to detect any potential toxic effects. As the famous Latin phrase reminds us, “sola dosis facit venenum” (the dose makes the poison) - even essential molecules like vitamins can be harmful if consumed in excessive amounts. This highlights the importance of determining the safe dosage for any substance we are exposed to. In the context of biorefinery technologies, understanding the balance between environmental friendliness and human safety is key to developing products that are both sustainable and non-toxic.

Zenodo (CERN European Organization for Nuclear Research)
University of Primorska (SI), University of the Basque Country (ES), InnoRenew CoE (SI), Aalto University (FI)
Responsible consumption and production
Openalex Percentile: Top 55%
MicroRNA in disease regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.